| 2168152
|
Pathogenicity for humans of human rhinovirus type 2 mutants resistant to or dependent on chalcone Ro 09-0410. |
Antimicrob Agents Chemother |
1990 |
Yasin SR;al-Nakib W;Tyrrell DA |
View
More |
| 2825590
|
Studies of rhinovirus resistant to an antiviral chalcone. |
Antiviral Res |
1987 |
Ahmad AL;Dowsett AB;Tyrrell DA |
View
More |
| 2988431
|
Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4\',6-dichloroflavan, and enviroxime. |
Antimicrob Agents Chemother |
1985 |
Ninomiya Y;Aoyama M;Umeda I;Suhara Y;Ishitsuka H |
View
More |
| 2996687
|
Rhinovirus colds. |
Br Med Bull |
1985 |
Phillpotts RJ;Tyrrell DA |
View
More |
| 3012583
|
Antiviral activity of flavones and flavans. |
Prog Clin Biol Res |
1986 |
Selway JW |
View
More |
| 3014575
|
Inhibitors of picornavirus uncoating as antiviral agents. |
Pharmacol Ther |
1985 |
Diana GD;Otto MJ;McKinlay MA |
View
More |
| 3017203
|
Synergism between anti-rhinovirus antivirals: various human interferons and a number of synthetic compounds. |
Antiviral Res |
1986 |
Ahmad AL;Tyrrell DA |
View
More |
| 3025150
|
Molecular basis of drug resistance to new antirhinovirus agents. |
J Antimicrob Chemother |
1986 |
Ishitsuka H;Ninomiya Y;Suhara Y |
View
More |
| 6094423
|
Evaluation of the antirhinovirus chalcone Ro 09-0415 given orally to volunteers. |
J Antimicrob Chemother |
1984 |
Phillpotts RJ;Higgins PG;Willman JS;Tyrrell DA;Lenox-Smith I |
View
More |
| 6100571
|
Antivirus agent, Ro 09-0410, binds to rhinovirus specifically and stabilizes the virus conformation. |
Virology |
1984 |
Ninomiya Y;Ohsawa C;Aoyama M;Umeda I;Suhara Y;Ishitsuka H |
View
More |
| 6295261
|
Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410. |
Antimicrob Agents Chemother |
1982 |
Ishitsuka H;Ninomiya YT;Ohsawa C;Fujiu M;Suhara Y |
View
More |
| 7811059
|
Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses. |
Antiviral Res |
1994 |
Dewindt B;van Eemeren K;Andries K |
View
More |
